drugset / Trial / NCT07538466

A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232

NCT07538466 ↗

Phase 1 Not yet recruiting 50 enrolled Addpharma Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232

Timeline

Start
2026-04
Primary completion
2026-05
Completion
2026-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AD-123 Unknown — Oral
Subject AD-1231 Unknown — Oral
Subject AD-1232 Unknown — Oral

Indications